SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech informs about earnings presentation

16 Aug 2021 Evaluate

Further to its intimation dated August 13, 2021, regarding approval of un-audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter ended June 30, 2021, Fermenta Biotech has informed that it enclosed a copy of Earnings Presentation for Quarter 1-Financial Year 2021-2022. The said Earnings Presentation will thereafter be uploaded on Company’s website at www.fermentabiotech.com.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

407.45 5.50 (1.37%)
24-Jul-2026 10:13 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1950.05
Dr. Reddys Labs. 1139.80
Cipla 1418.65
Lupin 2350.35
Zydus Lifesciences 1110.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: